Two Sigma Advisers’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Sell |
|
|||||
|
2025
Q1 | $1.31M | Sell |
|
|||||
|
2024
Q4 | $2.42M | Sell |
|
|||||
|
2024
Q3 | $1.5M | Sell |
|
|||||
|
2024
Q2 | $1.58M | Sell |
|
|||||
|
2024
Q1 | $1.8M | Buy |
|
|||||
|
2023
Q4 | $1.49M | Buy |
|
|||||
|
2023
Q3 | $1M | Buy |
|
|||||
|
2023
Q2 | $252K | Sell |
|
|||||
|
2023
Q1 | $328K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $193K | Sell |
|
|||||
|
2021
Q3 | $295K | Sell |
|
|||||
|
2021
Q2 | $1.28M | Buy |
|
|||||
|
2021
Q1 | $1.52M | Buy |
|
|||||
|
2020
Q4 | $305K | Buy |
|
|||||
|
2020
Q3 | $60K | Sell |
|
|||||
|
2020
Q2 | $42K | Sell |
|
|||||
|
2020
Q1 | $36K | Sell |
|
|||||
|
2019
Q4 | $109K | Sell |
|
|||||
|
2019
Q3 | $167K | Buy |
|